---
layout: post
title: "晨光生物一季度净利润预增21.72%-53.75%"
date: 2022-03-28 20:52:13 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.300138" data-code="300138|0|2" data-code2="300138|0|80|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300138&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 300138_0" data-code="K 300138|0|2" data-code2="K 300138|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>晨光生物披露一季度业绩预告。公司预计2022年第一季度盈利9,500万元-12,000万元，比上年同期增长21.72%至53.75%。报告期内，公司主产品及潜力品种多点开花，促进了公司业绩增长。<br /></p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203282325389857>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)